Endurance Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Endurance Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$144K	Sell	287 -300	-51%	-$144K	0.02%	233
2023 Q1	$148K	Buy	587 +300	+105%	+$144K	0.02%	226
2022 Q4	$117K	Hold	287	–	–	0.02%	237
2022 Q3	$94K	Hold	287	–	–	0.02%	252
2022 Q2	$101K	Hold	287	–	–	0.02%	253
2022 Q1	$157K	Hold	287	–	–	0.02%	226
2021 Q4	$189K	Hold	287	–	–	0.02%	218
2021 Q3	$178K	Hold	287	–	–	0.02%	222
2021 Q2	$181K	Hold	287	–	–	0.02%	222
2021 Q1	$140K	Buy	287 +267	+1,335%	+$134K	0.02%	250
2020 Q4	$10K	Hold	20	–	–	﹤0.01%	492
2020 Q3	$8K	Buy	+20	New	+$7.39K	﹤0.01%	498

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Endurance Wealth Management's IDXX Position: Q2 2023 in Review

Endurance Wealth Management reduced its Idexx Laboratories (IDXX) stake by 51% in Q2 2023, selling an estimated $144K and leaving 287 shares worth $144K. The position accounts for 0.02% of the portfolio, ranked #233.

Endurance Wealth Management first reported a position in IDXX in Q3 2020 and has held it in 12 quarters since. The position peaked at $189K in Q4 2021. 1,069 funds tracked by Wall St. Rank hold IDXX as of Q2 2023.

Endurance Wealth Management held 287 shares of Idexx Laboratories worth $144K as of Q2 2023.
Endurance Wealth Management sold 300 Idexx Laboratories shares in Q2 2023, an estimated $144K.
Idexx Laboratories made up 0.02% of Endurance Wealth Management's portfolio in Q2 2023, its #233 holding.
Endurance Wealth Management first reported a position in Idexx Laboratories in Q3 2020 and has held it in 12 quarters since.
Endurance Wealth Management's Idexx Laboratories position peaked at $189K in Q4 2021.
1,069 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2023.

Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.